970*90
768
468
mobile

USFDA completes Inspection of Suven Life Sciences' Pashamylaram facility

Franchise India Bureau
Franchise India Bureau May 08 2018 - 1 min read
USFDA completes Inspection of Suven Life Sciences' Pashamylaram facility
The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA).

Drug firm Suven Life Sciences has confirmed that its Pashamylaram facility near Hyderabad has undergone successful inspection by the US health regulator.

The facility has undergone renewal inspection from February 5-18 by the United States Food and Drug Administration (USFDA), Suven Life Sciences said in a filing to BSE.

The plant is considered to be in an acceptable state of compliance with regards to current good manufacturing practices (CGMP) and the agency has issued an Establishment Inspection Report (EIR) for the facility, it added.

So far the company has filed 19 Drug Master Files (DMF's) and 5 abbreviated new drug applications (ANDA's) from this facility, Suven said.

The company's stock was trading 5.43 per cent up at Rs 191.10 on BSE in the afternoon.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online